NCT07415031 2026-04-08
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
Mirati Therapeutics Inc.
Phase 2 Not yet recruiting
Mirati Therapeutics Inc.
Sichuan Baili Pharmaceutical Co., Ltd.
Catharina Ziekenhuis Eindhoven
Multitude Therapeutics Inc.
Children's Oncology Group
Qilu Pharmaceutical Co., Ltd.
Luye Pharma Group Ltd.
Sixth Affiliated Hospital, Sun Yat-sen University
Gruppo Oncologico Italia Meridionale
City of Hope Medical Center
Onconic Therapeutics Inc.